Page 3 - Nasdaq Cocp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq cocp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Cocp Today - Breaking & Trending Today

Cocrystal Pharma, Inc. (NASDAQ:COCP) Sees Significant Drop in Short Interest

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) was the recipient of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 1,900 shares, a decline of 50.0% from the February 28th total of 3,800 shares. Based on an average daily volume of 53,100 shares, the […] ....

Cocrystal Pharma , Cocrystal Pharma Inc , Cocrystal Pharma Company Profile , Get Rating , Cocrystal Pharma Daily , Nasdaq Cocp ,

Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Grows By 314.6%

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 241,300 shares, an increase of 314.6% from the May 15th total of 58,200 shares. Approximately 0.3% of the shares of the stock are short sold. Based on an average trading […] ....

Cocrystal Pharma , Cocrystal Pharma Inc , Geode Capital Management , Goldman Sachs Group Inc , Citadel Advisors , Barclays Plc , Get Rating , Sachs Group , Capital Management , Nasdaq Cocp ,

Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) saw a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 183,600 shares, a decrease of 36.4% from the March 31st total of 288,800 shares. Based on an average trading volume of 288,700 shares, the short-interest ratio is […] ....

Thomson Reuter , Cocrystal Pharma , Raymond James Financial Services Advisors Inc , Geode Capital Management , Goldman Sachs Group Inc , Zacks Investment Research , Cocrystal Pharma Inc , Citadel Advisors , Barclays Plc , Get Rating , Investment Research , James Financial Services Advisors , Sachs Group , Capital Management , Nasdaq Cocp ,

Zacks: Analysts Anticipate Cocrystal Pharma, Inc. (NASDAQ:COCP) Will Announce Quarterly Sales of $630,000.00

Wall Street analysts expect that Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) will report $630,000.00 in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Cocrystal Pharma’s earnings, with estimates ranging from $500,000.00 to $750,000.00. The company is scheduled to report its next earnings results on Monday, […] ....

Cocrystal Pharma , Cocrystal Pharma Inc , Raymond James Financial Services Advisors Inc , Jpmorgan Chase Co , Zacks Investment Research , Citadel Advisors , Barclays Plc , Wall Street , Get Rating , Zacks Investment , Investment Research , James Financial Services Advisors , Sigma Advisers , Nasdaq Cocp ,

Zacks: Brokerages Expect Cocrystal Pharma, Inc. (NASDAQ:COCP) to Post -$0.04 Earnings Per Share

Equities analysts expect Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Rating) to announce earnings per share (EPS) of ($0.04) for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Cocrystal Pharma’s earnings, with estimates ranging from ($0.04) to ($0.03). Cocrystal Pharma also posted earnings per share of ($0.04) in the same […] ....

Cocrystal Pharma , Cocrystal Pharma Inc , Raymond James Financial Services Advisors Inc , Goldman Sachs Group Inc , Zacks Investment Research , Cocrystal Pharma Company Profile Get Rating , Barclays Plc , Get Rating , Zacks Investment , Investment Research , James Financial Services Advisors , Sachs Group , Two Sigma Advisers , Pharma Company Profile , Nasdaq Cocp ,